Athenahealth Receives a Rating Update from a Top Analyst

By Austin Angelo

In a report released today, John Difucci from Jefferies maintained a Hold rating on Athenahealth (NASDAQ: ATHN), with a price target of $120. The company’s shares opened today at $130.38.

According to, Difucci is a top 25 analyst with an average return of 17.6% and a 76.0% success rate. Difucci covers the Technology sector, focusing on stocks such as SS&C Technologies Holdings, Callidus Software, and CommVault Systems.

Athenahealth has an analyst consensus of Moderate Buy, with a price target consensus of $155.92.

Based on Athenahealth’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $301 million and quarterly net profit of $9.9 million. In comparison, last year the company earned revenue of $262 million and had a GAAP net loss of $1.92 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

athenahealth, Inc. provides cloud-based business services and mobile applications for medical groups and health systems. It also provides ongoing billing, clinical-related, and other related services to customers. The company offers practice management and electronic health record services.